share_log

迈博药业-B(02181.HK)拟8月28日举行董事会会议批准中期业绩

MeiBo Pharmaceutical Group-B (02181.HK) plans to hold a board of directors meeting on August 28th to approve the mid-term performance.

Gelonghui Finance ·  Aug 15, 2024 16:42

On August 15th, Glowanews reported that Meaboyao-B (02181.HK) announced that the board of directors meeting will be held on Wednesday, August 28, 2024 to consider and approve the mid-term performance of the company and its subsidiaries, up to June 30, 2024, as well as to handle any other matters that may arise.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment